Results of the Phase 1 Open-Label Safety Study of Umbilical Cord Lining Mesenchymal Stromal/Stem Cells (Corlicyte ® ) to Heal Chronic Diabetic Foot Ulcers.

Cecilia C Low WangTae ChongGarrett MooreBenjamin EchalierNicola HaakonsenJames E CarterDavid MathesJudith HsiaToan Thang PhanIvor J LimBrian M Freed

Published in: Biomedicines (2024)

, a novel biologic therapy consisting of allogeneic umbilical cord lining MSCs, appeared safe and tolerable and resulted in a significant decrease in ulcer area, demonstrating its potential as a therapy for healing of chronic DFU.

Keyphrases

umbilical cord
mesenchymal stem cells
bone marrow
stem cells
open label
cell therapy
rheumatoid arthritis
randomized controlled trial
study protocol
radiation therapy
rectal cancer
high dose
locally advanced
replacement therapy